medigraphic.com
Revista Médica Sinergia

2022, Number 09

<< Back

Revista Médica Sinergia 2022; 7 (09)

Cervical cancer: overview

Víquez RKF, Araya CR, Hidalgo SMJ

Language: Spanish
References: 17
Page:
PDF size: 127.74 Kb.


ABSTRACT

Cervical cancer is a major public health problem in developing countries, which represents a current challenge due to high mortality, with 90 percent of deaths from this cause, which occurs in low- to middle-income countries. Cervical cancer comprises 8 percent of all cancers among women and is the fourth most common cancer in women after breast, colon, and lung cancers. Squamous cell carcinoma together with adenocarcinoma constitutes more than 98% of all types of cervical cancer. approximately one third of cancerous tumors are related to inflammation induced by microorganisms, in this case cervical cancer is closely related to the human papillomavirus, especially with types 16 and 18 involved in 99% of this type of cancer. It is important to note that the symptoms of cervical cancer generally occur in late stages of the disease, so prevention with screening methods is essential to diagnose both premalignant and cancerous lesions.


REFERENCES

  1. Osorio-Castaño J, Pérez-Villa M, Montoya-Zapata C, Cardona-Restrepo F. Características citológicas previas al diagnóstico de cáncer de cérvix en mujeres de Medellín (Colombia). Universidad y Salud. 2020;22(3):231-237. Doi: https://doi.org/10.22267/rus.202203.195

  2. Shu PM, Li RB, Xie DM, He YM, Wang X, Li Q. Clinical profile and treatment outcome of collision carcinoma in cervix. Medicine. March, 2020;99(11):e19131. Doi: 10.1097/MD.0000000000019131.

  3. Lu X, Jiang L, Zhang L, Zhu Y, Hu W, Wang J, Ruan X, Xu Z, Meng X, Gao J, Su X, Yan F.Immune Signature-Based Subtypes of Cervical Squamous Cell Carcinoma Tightly Associated with Human Papillomavirus Type 16 Expression, Molecular Features, and Clinical Outcome. Neoplasia. 2019;21(6):591-601. Doi: https://doi.org/10.1016/j.neo.2019.04.003

  4. Sarmiento Medina MI, Puerto de Amaya M. Factores de riesgo para cáncer de cuello uterino y resultados de prueba de Papanicolaou en adolescentes marginadas de Bogotá, Colombia. Revista Ciencias De La Salud. 2020;18(1):37-51. Doi: https://doi.org/10.12804/revistas.urosario.edu.co/revsalud/a.8746

  5. Carrero YN, Callejas DE, Mosquera JA. In situ immunopathological events in human cervical intraepithelial neoplasia and cervical cancer: Review. Translational Oncology. 2021;14(5). Doi: https://doi.org/10.1016/J.TRANON.2021.101058

  6. Feldman S, Goodman A, Peipert JF. Screening for cervical cancer in resource-rich settings. UpToDate. 2021. Disponible a partir de: https://login.binasss.idm.oclc.org/login?qurl=https://www.uptodate.com%2f

  7. Alfaro Cartín S, Hernández Steller H, Jiménez Jiménez G, Lami Casaus L. Consenso del tratamiento farmacológico del cáncer. 2021. Disponible a partir de: https://acomedcr.com/consenso-farmacologico-del-cancer/

  8. Laberiano Fernández CD. Estado del tamizaje del cáncer de cérvix en países de América Latina desde la perspectiva de los profesionales de salud. Rev Peru Ginecol Obstet. 2020;66(1):37-40. Doi: https://doi.org/10.31403/rpgo.v66i2231

  9. Denny L. Screening for cervical cancer in resource-limited settings. UpToDate. 2021. Disponible a partir de: https://login.binasss.idm.oclc.org/login?qurl=https://www.uptodate.com%2f

  10. De Vita V, Hellman S, Rosenberg S. Cancer: Principles and Practice of Oncology. Lippincont 11th edition. Wolters Kluwer. 2019.

  11. Karam A. Cáncer de cuello uterino en el embarazo. UpToDate,. 2021. Disponible a partir de: https://login.binasss.idm.oclc.org/login?qurl=https://www.uptodate.com%2fcontents%2fcervical-cancer-in-pregnancy%2fprint%3fsearch%3dcancer

  12. Leaño Berrios J, Orieth Mena Revollo L. Correlación citológica, colposcópica e histológica de lesiones precancerígenas en cérvix. Rev MedLa Paz. 2020. Disponible a partir de: https://login.binasss.idm.oclc.org/login?qurl

  13. Feldman S, Crum CP. Cervical cancer screening tests: Techniques for cervical cytology and human papillomavirus testing. UpToDate. 2021. Disponible a partir de: https://login.binasss.idm.oclc.org/login?qurl=https://www.uptodate.com%2f

  14. Denny L. Cervical cancer screening tests: Visual inspection methods. UpToDate. 2021. Disponible a partir de: https://login.binasss.idm.oclc.org/login?qurl=https://www.uptodate.com%2f

  15. Arbeláez-Vásquez A, et al. Implementación de la nueva guía práctica clínica para la detección ymanejo de lesiones precancerosas de cuello uterino en mujeres de la ciudad de Cali, Colombia. Infectio. 2020;24(1):20-26. Disponible a partir de: https://login.binasss.idm.oclc.org/login?qurl

  16. Marañón Cardonne T, Mastrapa Cantillo K, Flores Barroso Y, Vaillant Lora L, Landazuri Llago S. Prevención y control del cáncer de cuello uterino. Correo científico médico de Holguín. 2017.

  17. Lei J, Ploner A, Elfström KM, Wang J, Roth A, Fang F, Sundström K, Dillner J, Sparén P. HPV Vaccination and the Risk of Invasive Cervical Cancer. N Engl J M. 2020;383:1340-1348. Disponible a partir de: https://www.nejm.org/doi/full/10.1056/NEJMoa1917338




2020     |     www.medigraphic.com